Invectys Announces Initiation of Phase 1/2a Clinical Trial in Solid Tumors and Change in Leadership Houston, TX, USA, July 13, 2023 (GLOBE NEWSWIRE) -- Invectys, Inc., a clinical-stage immuno-oncology company developing novel therapies for the treatment of advanced cancers, today announces it has...